Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Mandiri Herindo Adiperkasa Tbk. (MAHA) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Mandiri Herindo Adiperkasa Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Mandiri Herindo Adiperkasa Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Mandiri Herindo Adiperkasa Tbk. trades at Rp141 (market cap 2.33T, 2.7M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Mandiri Herindo Adiperkasa Tbk. is far larger — about 13.9× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Mandiri Herindo Adiperkasa Tbk. is more actively traded (2.7M versus 96.7K). Which is the better fit depends on your goals.

MAHAOBAT
Market Cap
2.33T167.37B
Volume
2.7M96.7K
Lot
27K967
Turnover
378.94M23.82M
Average Price
140.36246.34
Value
378.94M23.82M
Indicative Equilibrium Price
142248
Indicative Equilibrium Volume
2041

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MAHA
View details
OBAT
View details

About Mandiri Herindo Adiperkasa Tbk.

PT Mandiri Herindo Adiperkasa Tbk. (the Company) is a limited liability company established in the Republic of Indonesia based on Notarial Deed of Julia Rochana Murat, S.H., No. 18 dated January 25, 1994. The Company started commercial activities in 1994.

Read more on MAHA

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT